Eli Lilly to Invest $6.5 Billion in Texas Manufacturing Hub for Obesity Pill and Other Pipeline Drugs
Novo Nordisk Shares Rise After Positive Phase 3 Trial Results for Experimental Weight-Loss Injection Cagrilintide, Offering New Hope in Obesity Treatment Market
Vaccine Makers’ Shares Drop Amid Report Linking Covid Shots to Child Deaths
AstraZeneca Puts $270 Million Cambridge Expansion On Hold Amid Shifting U.K. Business Climate
AbbVie Stock Hits All-Time High as Rinvoq Wins Four Extra Years of U.S. Market Exclusivity
Viking Therapeutics Shares Tumble 40% After Midstage Obesity Pill Trial Disappoints Investors
GoodRx Stock Surges After Novo Nordisk GLP-1 Deal at $499/Month
Gilead Sciences (GILD) Shares Are Surging After a Strong Q2
Eli Lilly Shares Slide as Obesity Pill Shows Modest Results in Late-Stage Trial
Pfizer CEO Touts 'Special Relationship' With Trump Amid Tariff, Drug Pricing Talks
Novo Nordisk Stock Craters as Wegovy and Ozempic Forecasts Get Slashed
Neuralink Eyes $1 Billion in Annual Revenue by 2031, Bloomberg Reports
Pump Radar
Stock Alerts